Insights

Loading spinner
Gathering insights about TME Pharma

TME Pharma Tech Stack

TME Pharma uses 8 technology products and services including Google Analytics, Joomla, Font Awesome, and more. Explore TME Pharma's tech stack below.

  • Google Analytics
    Analytics
  • Joomla
    Content Management System
  • Font Awesome
    Font Scripts
  • metisMenu
    Javascript Libraries
  • PHP
    Programming Languages
  • Bootstrap
    UI Frameworks
  • YouTube
    Video Players
  • Apache
    Web Servers

Media & News

TME Pharma's Email Address Formats

TME Pharma uses at least 2 format(s):
TME Pharma Email FormatsExamplePercentage
FLast@noxxon.comJDoe@noxxon.com
80%
First.L@noxxon.comJohn.D@noxxon.com
7%
LastFi@noxxon.comDoeJo@noxxon.com
3%
LFirst@noxxon.comDJohn@noxxon.com
3%
F_Last@noxxon.comJ_Doe@noxxon.com
4%
FirstLa@noxxon.comJohnDo@noxxon.com
3%
FLast@tmepharma.comJDoe@tmepharma.com
100%

Frequently Asked Questions

Where is TME Pharma's headquarters located?

Minus sign iconPlus sign icon
TME Pharma's main headquarters is located at Max-Dohrn-Str. 8-10 Berlin, 10589 DE. The company has employees across 3 continents, including EuropeNorth AmericaAfrica.

What is TME Pharma's phone number?

Minus sign iconPlus sign icon
You can contact TME Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is TME Pharma's official website and social media links?

Minus sign iconPlus sign icon
TME Pharma's official website is tmepharma.com and has social profiles on LinkedIn.

How much revenue does TME Pharma generate?

Minus sign iconPlus sign icon
As of January 2025, TME Pharma's annual revenue reached $3.8M.

What is TME Pharma's NAICS code?

Minus sign iconPlus sign icon
TME Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does TME Pharma have currently?

Minus sign iconPlus sign icon
As of January 2025, TME Pharma has approximately 20 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Head Of It: C. M.(acting) Head Of Quality Assurance: R. B.Vp Project Management & Preclinical Development: D. E.. Explore TME Pharma's employee directory with LeadIQ.

What industry does TME Pharma belong to?

Minus sign iconPlus sign icon
TME Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does TME Pharma use?

Minus sign iconPlus sign icon
TME Pharma's tech stack includes Google AnalyticsJoomlaFont AwesomemetisMenuPHPBootstrapYouTubeApache.

What is TME Pharma's email format?

Minus sign iconPlus sign icon
TME Pharma's email format typically follows the pattern of . Find more TME Pharma email formats with LeadIQ.

When was TME Pharma founded?

Minus sign iconPlus sign icon
TME Pharma was founded in 1998.
TME Pharma

TME Pharma

Pharmaceutical ManufacturingBerlin, Germany11-50 Employees

TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. TME Pharma’s mission is to improve treatment outcomes for patients with cancer where TME significantly limits survival. The lead compound NOX-A12 acts in two distinct mechanisms of action, presenting great potential for developing this asset in various oncology indications. Currently, TME Pharma is focused on brain cancer (glioblastoma, GBM), with promising topline clinical results.
NOXXON's Spiegelmer® platform has generated a proprietary pipeline of clinical-stage assets including its lead cancer candidate NOX-A12, which is the subject of a clinical immuno-oncology collaboration agreement with Merck & Co. / MSD (NYSE: MRK) to study NOX-A12 combined with KEYTRUDA® (pembrolizumab) in pancreatic and colorectal cancer. NOXXON’s pipeline also contains NOX-E36, which targets other tumor microenvironment targets implicated in cancer spread and immune privilege of tumors.

Section iconCompany Overview

Headquarters
Max-Dohrn-Str. 8-10 Berlin, 10589 DE
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1998
Employees
11-50

Section iconFunding & Financials

  • $10M

    TME Pharma's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    TME Pharma's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.